Severe Sleep Apnea Tied to Acute CV Events
| By HospiMedica International staff writers Posted on 20 Mar 2018 | 

Image: A new study suggests OSA during REM sleep increases risk of cardiovascluar events (Photo courtesy of Alamy).
			
			Severe obstructive sleep apnea (OSA) occurring during rapid eye movement (REM) sleep is associated with recurrent events in people with pre-existing cardiovascular disease (CVD), according to a new study.
Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions conducted a study involving 3,265 participants in order to examine the association between OSA during REM sleep and a composite cardiovascular endpoint, both with and without prevalent CVD. All patients underwent full-montage home polysomnography, and were followed for an average of 9.5 years, during which time cardiovascular events were assessed.
The study only included participants with a non-REM apnea–hypopnea index (AHI) of less than five events per hour. The composite cardiovascular endpoint was occurrence of myocardial infarction (MI), coronary artery revascularization, congestive heart failure (CHF), and stroke. The results revealed that the adjusted hazard ratio (HR) for the composite cardiovascular end point among patients with severe REM OSA was 1.35. The association was most notable in those with prevalent CVD, with an adjusted hazard ratio of 2.56. The study was published in the March 1, 2018, issue of the American Journal of Respiratory and Critical Care Medicine.
“Severe OSA that is present only during REM sleep is associated with recurrent cardiovascular events in people who have prevalent cardiovascular disease,” concluded senior author Professor Naresh Punjabi, MD, PhD, of JHU, and colleagues. “With such mounting evidence indicating the range of clinical effects of sleep apnea, awareness amongst health care professionals and the general community needs to increase.”
In OSA, the muscles in the throat close in and block the airway during sleep. These gaps in breathing cause blood pressure to go up, as oxygen level in the body fall and the brain sends signals to the blood vessels to contract, so that oxygen flow to the heart and brain increases. Continuous positive airway pressure (CPAP) is the most commonly prescribed treatment for OSA, involving a mask worn during sleep that pumps air to help prevent the airway from closing.
Related Links:
Johns Hopkins University
Harvard Medical School
		
			
			
		
        		        
		        Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions conducted a study involving 3,265 participants in order to examine the association between OSA during REM sleep and a composite cardiovascular endpoint, both with and without prevalent CVD. All patients underwent full-montage home polysomnography, and were followed for an average of 9.5 years, during which time cardiovascular events were assessed.
The study only included participants with a non-REM apnea–hypopnea index (AHI) of less than five events per hour. The composite cardiovascular endpoint was occurrence of myocardial infarction (MI), coronary artery revascularization, congestive heart failure (CHF), and stroke. The results revealed that the adjusted hazard ratio (HR) for the composite cardiovascular end point among patients with severe REM OSA was 1.35. The association was most notable in those with prevalent CVD, with an adjusted hazard ratio of 2.56. The study was published in the March 1, 2018, issue of the American Journal of Respiratory and Critical Care Medicine.
“Severe OSA that is present only during REM sleep is associated with recurrent cardiovascular events in people who have prevalent cardiovascular disease,” concluded senior author Professor Naresh Punjabi, MD, PhD, of JHU, and colleagues. “With such mounting evidence indicating the range of clinical effects of sleep apnea, awareness amongst health care professionals and the general community needs to increase.”
In OSA, the muscles in the throat close in and block the airway during sleep. These gaps in breathing cause blood pressure to go up, as oxygen level in the body fall and the brain sends signals to the blood vessels to contract, so that oxygen flow to the heart and brain increases. Continuous positive airway pressure (CPAP) is the most commonly prescribed treatment for OSA, involving a mask worn during sleep that pumps air to help prevent the airway from closing.
Related Links:
Johns Hopkins University
Harvard Medical School
Latest Critical Care News
- 'Universal' Kidney to Match Any Blood Type
- Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
- AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
- Smartphone Imaging System Enables Early Oral Cancer Detection
- Swallowable Pill-Sized Bioprinter Treats GI Tract Injuries  
- Personalized Brain “Pacemakers” Could Help Patients with Hard-To-Treat Epilepsy
- Microscopic DNA Flower Robots to Enable Precision Medicine Delivery
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
- Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment
- AI System Reveals Hidden Diagnostic Patterns in Electronic Health Records
- Highly Sensitive On-Skin Sensing Monitor Detects Vitamin B6 and Glucose in Sweat
- Artificial Intelligence Revolutionizing Pediatric Anesthesia Management
Channels
Surgical Techniques
view channel 
                    Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read more 
                    Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read morePatient Care
view channel 
                    Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more 
                    VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more 
                    Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more 
                    First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel 
                    Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel 
                    Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more 
                    B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more 
                    CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more 
                    















 
								

 
								
 
								 
                     
                     
                    